Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/05/2013US8575209 Modulators of ATP-binding cassette transporters
11/05/2013US8575208 Inhibitors of serine proteases
11/05/2013US8575207 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
11/05/2013US8575206 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
11/05/2013US8575205 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575203 Chemical compounds
11/05/2013US8575202 Chelator stabilized cationic ammonium compounds and compositions comprising the same
11/05/2013US8575201 Oxadiazole inhibitors of leukotriene production
11/05/2013US8575200 Pyridin-2-yl derivatives as immunomodulating agents
11/05/2013US8575199 Formula (IA″) compounds comprising (piperidin-4-yl)pyridine or (1,2,3,6-tetrahydropyridin-4-4yl) as TRPV1 antagonists
11/05/2013US8575197 Pyrolinone derivative and pharmaceutical composition comprising the same
11/05/2013US8575196 Oligomer-opioid agonist conjugates
11/05/2013US8575195 Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
11/05/2013US8575194 Treatment methods of cognitive, emotional and mental ailments and disorders
11/05/2013US8575193 N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
11/05/2013US8575192 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
11/05/2013US8575191 Methods for treatment of non-small cell lung cancer
11/05/2013US8575190 Method of preventing or ameliorating psoriasis using pyrroloquinoline quinone compounds
11/05/2013US8575189 Tacrolimus preparation for external applications
11/05/2013US8575188 Camptothecin derivatives
11/05/2013US8575186 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
11/05/2013US8575185 Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
11/05/2013US8575184 Quinazolines as potassium ion channel inhibitors
11/05/2013US8575183 Heterocyclic compounds and their uses
11/05/2013US8575182 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
11/05/2013US8575181 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
11/05/2013US8575180 9-substituted 8-oxoadenine compound
11/05/2013US8575179 Dihydropyrazolopyrimidinone derivatives
11/05/2013US8575178 Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators
11/05/2013US8575177 Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
11/05/2013US8575176 Heteroaromatic pyrazinoylguanidine sodium channel blockers
11/05/2013US8575175 Therapeutic agent for chronic renal failure
11/05/2013US8575174 Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
11/05/2013US8575173 Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists
11/05/2013US8575172 Pharmaceutical compositions of aripiprazole
11/05/2013US8575171 Methods and compositions for treating thyroid-related medical conditions with reduced folates
11/05/2013US8575170 Flurbiprofen analogs and methods of use in treating cancer
11/05/2013US8575169 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
11/05/2013US8575168 Compounds and compositions as modulators of GPR119 activity
11/05/2013US8575167 Spiro compounds having stearoyl-CoA desaturase action
11/05/2013US8575166 Phthalazine-containing antidiabetic compounds
11/05/2013US8575165 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
11/05/2013US8575164 Combination cancer therapy
11/05/2013US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
11/05/2013US8575162 Compounds
11/05/2013US8575161 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
11/05/2013US8575160 Imidazole derivatives as aldosterone synthase inhibitors
11/05/2013US8575159 Triazine compounds as PI3 kinase and mTOR inhibitors
11/05/2013US8575157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2013US8575156 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
11/05/2013US8575155 Composition and method to modify sperm function and increase male gender ratio in mammals
11/05/2013US8575154 Heterocyclic compound and use thereof
11/05/2013US8575153 Pyridine-3-carboxyamide derivative
11/05/2013US8575152 Non-steroidal compounds useful as glucocorticoid receptor modulators
11/05/2013US8575151 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
11/05/2013US8575150 Triazole derivatives for treatment of Alzheimer's disease
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575148 Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers
11/05/2013US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions
11/05/2013US8575146 Pharmaceutical uses of staurosporine derivatives
11/05/2013US8575145 Triazolopyridine compounds as PIM kinase inhibitors
11/05/2013US8575144 Beta-lactamase inhibitory compounds
11/05/2013US8575142 Agent for improving insulin resistance
11/05/2013US8575141 Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
11/05/2013US8575140 Treatment of congestion using steroids and adrenergics
11/05/2013US8575139 Use of testosterone and a 5-HT1a agonist in the treatment of sexual dysfunction
11/05/2013US8575138 Method for providing neuroprotection
11/05/2013US8575137 Composition for inhalation
11/05/2013US8575136 2-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
11/05/2013US8575135 Antiviral compounds
11/05/2013US8575132 Modified starch material of biocompatible hemostasis
11/05/2013US8575131 Glucuronic acid-containing glucan, process for production of same, and use of same
11/05/2013US8575130 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
11/05/2013US8575129 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
11/05/2013US8575128 Methods for transdifferentiation of body tissues
11/05/2013US8575127 Antithrombotic diadenosine tetraphosphates and related analogs
11/05/2013US8575119 2′-chloroacetylenyl substituted nucleoside derivatives
11/05/2013US8575118 Antiviral compounds
11/05/2013US8575117 Proliferation inhibitor of helicobacter pylori including alpha-n-acetyl-glucosaminyl bond-containing monosaccharide derivatives
11/05/2013US8575116 Polyacetylenic compounds for protecting against pancreatic islet atrophy
11/05/2013US8575115 Crystalline form I of 3,4′5-trihydroxy-stilbene-3-β-D glucoside
11/05/2013US8575114 SGLT-2 inhibitors, methods of making them, and uses thereof
11/05/2013US8575108 Cyclosporin compositions
11/05/2013US8575092 Gelling hydrophobic injectable polymer compositions
11/05/2013US8575065 Acrylate/methacrylate-based star copolymer/anthranilic diamide compositions for propagle coating
11/05/2013US8574828 Controlled platelet activation to monitor therapy of ADP antagonists
11/05/2013US8574659 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
11/05/2013US8574634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions
11/05/2013US8574633 Huperzia serrata (Thunb.) Trev. composition comprising compounded Huperzine A and Huperzine B and methods for preparing it
11/05/2013US8574630 Corticosteroid particles and method of production
11/05/2013US8574622 Controlled release delivery system for nasal applications
11/05/2013US8574621 Adhesive patch for treatment of tinea unguium
11/05/2013US8574613 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
11/05/2013US8574607 Spiroheterocyclic thiofuran dione derivatives
11/05/2013US8574599 Methods and products for inducing mucosal immunity
11/05/2013US8574569 Stabilized protease composition
11/05/2013US8574568 Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
11/05/2013US8574563 Hepatitis C virus inhibitors
11/05/2013US8574562 Microemulsion pharmaceutical composition comprising a macrolide immunosuppressant drug